Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Investment Group Regulatory News (IIG)

Share Price Information for Intuitive Investment Group (IIG)

Share Price is delayed by 15 minutes
Get Live Data
238.00    -2.00 (-0.83%)
Bid:
230.00
Ask:
246.00
Spread: 16.00 (6.957%)
Market Cap: £569.55m
IIG Live PriceLast checked at - London Stock Exchange

Intraday Intuitive Investment Group Share Chart

Light Science Technologies - Intention To Float

12 Oct 2021 09:48

RNS Number : 7971O
Intuitive Investments Group plc
12 October 2021
 

Intuitive Investments Group plc

 

Light Science Technologies Holdings plc's Intention To Float Announcement

 

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, notes the intention to float announcement, released today by Light Science Technologies Holdings plc ("LSTH"), in relation to the proposed admission of LSTH's ordinary shares to trading on AIM ("Admission").

 

IIG's investment in LSTH consists of £1 million of convertible loan notes, which have a 7.25% coupon and will convert automatically at a 20% discount to LSTH's ordinary share price at Admission. IIG has also subscribed for an amount of ordinary shares equal to the interest and non-executive directors' fees due up to the date of Admission of £78,000 in the conditional placing associated with the flotation. IIG expects to receive, in aggregate, 13,280,000 ordinary shares in LSTH, representing 7.6% of its issued share capital on Admission. Admission is expected to take place on 15 October 2021.

 

LSTH was IIG's first investment from its pipeline of opportunities, following its successful IPO and Admission to AIM in December 2020.

 

For further information, please contact:

 

Intuitive Investments Group plc

www.iigplc.com

David Evans, Executive Chairman

Robert Naylor, CEO

Via Walbrook PR

 

 

Strand Hanson Limited - Nominated Adviser

+44 (0) 20 7409 3494

James Dance / James Bellman

 

 

 

 

Turner Pope Investments (TPI) Ltd - Broker

+44 (0) 20 3657 0050

Andrew Thacker / James Pope

 

 

 

Walbrook PR Limited - Media & Investor Relations

+44 (0)20 7933 8780 or intuitive@walbrookpr.com

Paul McManus

+44 (0) 7980 541 893

 

 

About Intuitive Investments Group plc

The Company is a recently established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZMMGRZGGMZG
Date   Source Headline
15th Oct 20218:01 amRNSLight Science Technologies Holdings - Floatation
12th Oct 20219:48 amRNSLight Science Technologies - Intention To Float
20th Sep 20218:04 amRNSLight Science Technologies Holdings - update
15th Sep 20217:00 amRNSInvestment in Momentum Bioscience Limited
20th Aug 20213:40 pmRNSDirector Dealing
29th Jun 202110:56 amRNSInvestment in Midatech Pharma PLC
2nd Jun 20217:00 amRNSInterim report
28th May 20212:18 pmRNSInvestment in Trellus Health plc
4th May 20217:00 amRNSInvestment in The Electrospinning Company Limited
9th Apr 202111:01 amRNSIssue of Shares and Total Voting Rights
1st Apr 20217:00 amRNSInvestment in Axol Bioscience Ltd
31st Mar 20214:18 pmRNSInvestment in Altair
31st Mar 202112:00 pmRNSInvestment in CardiNor AS
17th Mar 20217:00 amRNSInvestment in Polarean Imaging plc
16th Mar 20217:00 amRNSInvestment in Micrima Limited
1st Mar 20217:00 amRNSInvestment in Shield Therapeutics plc
22nd Feb 20217:00 amRNSInvestment in Yourgene Health plc
12th Feb 202111:41 amRNSProposed Investment in Kromek Pharma plc
8th Feb 202111:08 amRNSHolding(s) in Company
3rd Feb 20217:00 amRNSProposed Investment in Evgen Pharma plc
29th Jan 20217:00 amRNSPortfolio company BioQ Pharma receives CE mark
25th Jan 20217:00 amRNSProposed Investment in Microsaic Systems plc
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSInvestment in BioQ Pharma
11th Jan 20217:00 amRNSPre-IPO Investment in Light Science Technologies
14th Dec 20207:00 amRNSAIM Admission & First Day of Dealings
17th Jul 200610:58 amPRNDirector/PDMR Shareholding
30th Jun 200610:19 amPRNIssue of Equity
20th Jun 20063:08 pmPRNDirector/PDMR Shareholding
2nd Jun 200612:20 pmPRNCorrection : Holding(s) in Company
2nd Jun 200612:05 pmPRNHolding(s) in Company
16th May 200610:35 amPRNDirector/PDMR Shareholding
8th May 20062:30 pmPRNAdditional Listing
27th Apr 20061:07 pmPRNDirectorate Change
13th Apr 20069:46 amPRNDirector/PDMR Shareholding
23rd Mar 20064:53 pmPRNAdditional Listing
13th Mar 200610:41 amPRNDirector/PDMR Shareholding
8th Mar 20063:42 pmPRNNotice of Results
22nd Feb 20064:45 pmPRNDirector/PDMR Shareholding
18th Jan 20065:07 pmPRNDirector/PDMR Shareholding
3rd Jan 20068:30 amPRNTrading Statement
21st Dec 20052:54 pmPRNAdditional Listing
20th Dec 200512:16 pmPRNDirector/PDMR Shareholding
20th Dec 200510:51 amPRNAllotment of Shares
12th Oct 20054:18 pmPRNCirc re Interim Results
4th Oct 20052:44 pmPRNAllotment of shares
29th Sep 20059:40 amPRNHolding(s) in Company
29th Sep 20059:35 amPRNDirectorate Change
29th Sep 20056:00 amPRNInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.